08045804946
Send Inquiry
ZYCEVA 150MG
3200.0 INR/Number
Product Details:
- Indication Treatment of Non-Small Cell Lung Cancer, Pancreatic Cancer
- Brand Name ZYCEVA 150MG
- Dosage Form Oral Tablet
- Salt Composition Erlotinib Hydrochloride
- Packaging Type Blister Pack
- Life Span 36 months from manufacturing
- Origin of Medicine India
- Click to View more
X
ZYCEVA 150MG Price And Quantity
- 1 Number
- 3200.0 INR/Number
- 30043919
- Cadila Healthcare Ltd.
- Rash, diarrhea, anorexia, fatigue, breathlessness
- D (Positive evidence of risk)
- Antineoplastic Agents
- Oral
- White to off-white
- Prescription
- To be sold by retail on the prescription of an Oncologist only
ZYCEVA 150MG Product Specifications
- Treatment of Non-Small Cell Lung Cancer, Pancreatic Cancer
- Non-Small Cell Lung Cancer, Pancreatic Cancer
- Erlotinib Hydrochloride 150mg
- Prescription Only
- Anticancer medication (EGFR inhibitor)
- Oral Tablet
- ZYCEVA 150MG
- 30 Tablets in a box
- Store below 30C, protect from moisture and light
- India
- 36 months from manufacturing
- Tablet
- Adults
- Erlotinib Hydrochloride
- Blister Pack
- Take orally, preferably at least one hour before or two hours after food
- As directed by Oncologist
- 30 Tablets
- 30043919
- Cadila Healthcare Ltd.
- Rash, diarrhea, anorexia, fatigue, breathlessness
- D (Positive evidence of risk)
- Antineoplastic Agents
- Oral
- White to off-white
- Prescription
- To be sold by retail on the prescription of an Oncologist only
ZYCEVA 150MG Trade Information
- Cash Advance (CA), Cash on Delivery (COD), Cash in Advance (CID)
- 1000 Number Per Week
- 2 Days
- No
- North America, South America, Asia, Australia, Central America, Eastern Europe, Western Europe, Middle East, Africa
- All India
Product Description
- Active Ingredient: Erlotinib (150 mg)
- Manufacturer: Zydus Cadila
- Mechanism of Action: It is a targeted therapy that blocks the action of an abnormal protein that signals cancer cells to multiply, thereby slowing or stopping the spread of cancerous cells.
- Uses:
- Non-small cell lung cancer (NSCLC): Used for locally advanced or metastatic NSCLC, particularly in patients whose cancer cells have specific EGFR mutations.
- Pancreatic cancer: Used in combination with gemcitabine to treat advanced or metastatic pancreatic cancer.
Important Considerations
- Administration: The tablet should be taken orally once daily on an empty stomach, at least one hour before or two hours after a meal. It should be swallowed whole.
- Side Effects: Common side effects include rash, diarrhea, nausea, vomiting, fatigue, and weight loss. The doctor should be informed of any severe or persistent side effects, especially severe diarrhea, vision changes, or breathing difficulties.
- Precautions:
- Smoking: Smoking should be avoided during treatment as it can significantly decrease the medication's effectiveness.
- Sunlight: The medicine makes skin sensitive to sunlight; protective clothing and sunscreen should be used outdoors.
- Pregnancy/Breastfeeding: It is not recommended during pregnancy or breastfeeding, and effective contraception is necessary during treatment and for a period after the last dose.
- Drug Interactions: Inform your doctor about all other medications being taken, as many can interact with Zyceva 150 mg, especially antacids or other stomach acid-reducing medicines, which should be taken at least 2 hours apart.
- Monitoring: Regular blood tests may be advised by your doctor to monitor liver function during the course of treatment.
Targeted Therapy for Advanced Cancers
ZYCEVA 150MG provides targeted therapy through its active ingredient, Erlotinib Hydrochloride, specifically inhibiting cancer cell growth in non-small cell lung cancer and pancreatic cancer. This precision medicine helps maximize effectiveness while minimizing harm to healthy tissues, improving cancer management outcomes for eligible adult patients.
Usage and Administration Guidelines
The medication should be taken orally, either at least one hour before or two hours after eating, as directed by an oncologist. Following the correct timing enhances drug absorption and effectiveness. Dosage is determined by your oncologist based on medical need. Always adhere to prescribed instructions to ensure optimal benefit and safety.
Safety and Storage Precautions
ZYCEVA 150MG is a prescription-only medicine that must be sold by retail solely on an oncologist's prescription. Store the tablets below 30C, protected from moisture and light, to maintain efficacy throughout their 36-month shelf life. Due to its pregnancy category D status, it poses a risk to pregnancies and requires careful consideration by healthcare providers.
FAQ's of ZYCEVA 150MG:
Q: How should I take ZYCEVA 150MG for optimal results?
A: Take ZYCEVA 150MG orally, preferably at least one hour before or two hours after food, as this method increases absorption and effectiveness. Always follow the dosage and timing as directed by your oncologist.Q: What are the main benefits of using ZYCEVA 150MG in cancer treatment?
A: ZYCEVA 150MG targets and inhibits specific growth pathways in non-small cell lung cancer and pancreatic cancer cells, helping to slow or stop cancer progression, which provides meaningful benefits for managing advanced cancers.Q: When should I contact my healthcare provider while using ZYCEVA 150MG?
A: Contact your oncologist immediately if you experience severe side effects such as persistent rash, diarrhea, fatigue, breathlessness, or any other symptoms that concern you. Close monitoring helps manage potential adverse reactions promptly.Q: What important warnings should I know about ZYCEVA 150MG usage?
A: ZYCEVA 150MG is for prescription-only use under an oncologist's supervision and is not suitable during pregnancy due to positive evidence of risk (Pregnancy Category D). It should be kept out of reach of children and not shared with others.Q: Where should I store ZYCEVA 150MG tablets?
A: Store the tablets in their original blister pack below 30C, protected from light and moisture. Appropriate storage maintains their effectiveness for up to 36 months from the manufacturing date.Q: What are the possible side effects of ZYCEVA 150MG?
A: Common side effects may include rash, diarrhea, appetite loss (anorexia), fatigue, and breathlessness. It's important to inform your healthcare provider if you notice any side effects, so they can assist you in managing them.Tell us about your requirement
Price:
Quantity
Select Unit
- 50
- 100
- 200
- 250
- 500
- 1000+
Additional detail
Mobile number
Email
Other Products in 'Anti Cancer Medicines' category
Contact Us
- Office No. - 5, Ground Floor, D R Shopping Center, Dattapada Road, Near Hdfc Bank, Borivali East,Mumbai - 400066, Maharashtra, India
- Phone : 08045804946
- Mr Ranjeet Singh (CEO & Founder)
- Mobile : 08045804946
- medisus.pharma007@gmail.com
Send Inquiry
Send SMSMEDISUS PHARMA
All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.
Developed and Managed by Infocom Network Private Limited.
